TGRP — Nanopharmaceutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- $104.40m
- $103.36m
- $1.48m
Annual cashflow statement for Nanopharmaceutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0.909 | -1.22 |
| Depreciation | ||
| Non-Cash Items | 0.015 | 0.431 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.127 | 0.168 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -0.805 | -0.504 |
| Capital Expenditures | -0.088 | -0.019 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 0.001 | 0 |
| Sale of Fixed Assets | ||
| Cash from Investing Activities | -0.088 | -0.019 |
| Financing Cash Flow Items | 0.442 | 1.1 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0.478 | 1.09 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -0.112 | -0.253 |